Premium
Balloon mitral valvuloplasty during pregnancy
Author(s) -
Routray S.N.,
Mishra T.K.,
Swain S.,
Patnaik U.K.,
Behera M.
Publication year - 2004
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2003.09.005
Subject(s) - medicine , pregnancy , miscarriage , abortion , tamponade , balloon , gestation , maternal death , obstetrics , intrauterine growth restriction , mitral valve stenosis , stenosis , mitral valve , surgery , gynecology , cardiology , population , genetics , environmental health , biology
Objectives : Balloon mitral valvuloplasty (BMV) has been performed safely during pregnancy with good results. Reports are few on long‐term effects of BMV on childhood development. Methods : BMV was performed in 40 pregnant women (age 23.4±4.8 years) with severe mitral stenosis at 24.2±4.6 weeks of gestation. Results : Mitral valve area increased from 0.82±0.34 to 1.9±0.4 cm 2 ( P <0.001). One patient had pericardial tamponade. Mean fluoroscopy time was 5.5±3.8 min. There was no maternal death, no abortion, no intrauterine growth restriction and one stillbirth. All 39 babies were normal at birth. One baby died at 7 months due to pneumonia. On follow up for 36±15 months, all 38 babies maintained normal growth and development without any thyroid disease or malignancy. Conclusions : During pregnancy BMV is feasible, safe and effective. Maternal and fetal outcomes are excellent. Growth and milestone of development are not affected.